Lissy de Ridder

10.3k total citations · 1 hit paper
124 papers, 3.4k citations indexed

About

Lissy de Ridder is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Lissy de Ridder has authored 124 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Genetics, 49 papers in Epidemiology and 44 papers in Surgery. Recurrent topics in Lissy de Ridder's work include Inflammatory Bowel Disease (82 papers), Microscopic Colitis (47 papers) and Adolescent and Pediatric Healthcare (21 papers). Lissy de Ridder is often cited by papers focused on Inflammatory Bowel Disease (82 papers), Microscopic Colitis (47 papers) and Adolescent and Pediatric Healthcare (21 papers). Lissy de Ridder collaborates with scholars based in Netherlands, United Kingdom and Israel. Lissy de Ridder's co-authors include Johanna C. Escher, Dan Turner, Frank M. Ruemmele, Richard K. Russell, Jorge Amil Dias, Arie Levine, Sibylle Koletzko, Gábor Veres, Paolo Lionetti and Anders Pærregaard and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Lissy de Ridder

115 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

2013 958 citations Arie Levine, Sibylle Koletzko et al. Journal of Pediatric Gastroenterology and Nutrition profile →

Peers

Lissy de Ridder

GENET

EPIDE

SURGE

IMMUN

PHEOH

Joel R. Rosh United States

Miguel Regueiro United States

Mark T. Osterman United States

Mary Zachos Canada

Jonathan E. Markowitz United States

Jingdong Chao United States

Jonathan Evans United States

Stefano Martelossi Italy

William Connell Australia

Waqqas Afif Canada

Joel R. Rosh United States

Lissy de Ridder

2.4k ×1.0

GENET

1.7k ×1.1

EPIDE

1.0k ×0.8

SURGE

648 ×0.8

IMMUN

394 ×1.1

PHEOH

Citations per year, relative to Lissy de Ridder Lissy de Ridder (= 1×) peers Joel R. Rosh

Countries citing papers authored by Lissy de Ridder

Since Specialization

Citations

This map shows the geographic impact of Lissy de Ridder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lissy de Ridder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lissy de Ridder more than expected).

Fields of papers citing papers by Lissy de Ridder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lissy de Ridder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lissy de Ridder. The network helps show where Lissy de Ridder may publish in the future.

Co-authorship network of co-authors of Lissy de Ridder

This figure shows the co-authorship network connecting the top 25 collaborators of Lissy de Ridder. A scholar is included among the top collaborators of Lissy de Ridder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lissy de Ridder. Lissy de Ridder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hauer, Almuthe, Mutaz Sultan, Andy Darma, et al.. (2025). Management of pediatric inflammatory bowel diseases in limited‐resource settings: A position paper from the Paediatric IBD Porto Group of ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition. 81(3). 866–898. 2 indexed citations

Zhang, Zhengxiao, Gili Focht, Víctor Manuel Navas‐López, et al.. (2024). Serum Metabolites Relate to Mucosal and Transmural Inflammation in Paediatric Crohn Disease. Journal of Crohn s and Colitis. 18(11). 1832–1844. 2 indexed citations

Kemos, Polychronis, et al.. (2024). P274 Renal failure in children with inflammatory bowel disease. Journal of Crohn s and Colitis. 18(Supplement_1). i633–i634.

Tindemans, Irma, M Aardoom, L M M Costes, et al.. (2024). Gut-homing and intestinal TIGITnegCD38+ memory T cells acquire an IL-12-induced, ex-Th17 pathogenic phenotype in a subgroup of Crohn’s disease patients with a severe disease course. Mucosal Immunology. 18(2). 299–311. 1 indexed citations

Gerasimidis, Konstantinos, Richard K. Russell, Amit Assa, et al.. (2023). Precision nutrition in pediatric IBD: A position paper from the ESPGHAN special interest group for basic science and translational research, the IBD Porto group, and allied health professionals. Journal of Pediatric Gastroenterology and Nutrition. 78(2). 428–445. 6 indexed citations

Cozijnsen, Martinus A., Tim de Meij, Obbe F. Norbruis, et al.. (2023). P448 Long term effectiveness of first-line infliximab treatment compared to conventional treatment in paediatric moderate-to-severe Crohn’s disease – an update from the TISKids study. Journal of Crohn s and Colitis. 17(Supplement_1). i579–i580. 1 indexed citations

Torrente, Franco, Susanna Meade, Eric I. Benchimol, et al.. (2022). Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel. Journal of Crohn s and Colitis. 16(10). 1609–1616. 7 indexed citations

Neyt, Mattias, Marina Aloi, Lissy de Ridder, et al.. (2020). Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment. JMIR Formative Research. 5(1). e13888–e13888. 1 indexed citations

Aardoom, M, Polychronis Kemos, Irma Tindemans, et al.. (2020). International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study. BMJ Open. 10(7). e035538–e035538. 9 indexed citations

10.

Huynh, Hien Q., Lorenzo Norsa, Séamus Hussey, et al.. (2020). Infliximab in young paediatric IBD patients: it is all about the dosing. European Journal of Pediatrics. 179(12). 1935–1944. 56 indexed citations

11.

Harris, Rachel E., Marina Aloi, Lissy de Ridder, et al.. (2020). Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course. BMJ Open. 10(7). e034892–e034892. 6 indexed citations

12.

Breij, Laura M., et al.. (2013). Self-efficacy in adolescents with inflammatory bowel disease: A pilot study of the “IBD-yourself”, a disease-specific questionnaire. Journal of Crohn s and Colitis. 7(9). e375–e385. 57 indexed citations

13.

Ridder, Lissy de, Merit M. Tabbers, & Johanna C. Escher. (2012). Small bowel endoscopy in children. Best Practice & Research Clinical Gastroenterology. 26(3). 337–345. 9 indexed citations

14.

Nardo, Giovanni Di, Lissy de Ridder, Salvatore Oliva, et al.. (2012). Enteroscopy in paediatric Crohn's disease. Digestive and Liver Disease. 45(5). 351–355. 10 indexed citations

15.

Bie, Charlotte I. de, Johanna C. Escher, & Lissy de Ridder. (2011). Antitumor necrosis factor treatment for pediatric inflammatory bowel disease. Inflammatory Bowel Diseases. 18(5). 985–1002. 37 indexed citations

16.

Bie, Charlotte I. de, Thalia Hummel, Angelika Kindermann, et al.. (2010). The duration of effect of infliximab maintenance treatment in paediatric Crohn’s disease is limited. Alimentary Pharmacology & Therapeutics. 33(2). 243–250. 60 indexed citations

17.

Aktaş, Hüseyin, Lissy de Ridder, Jelle Haringsma, Ernst J. Kuipers, & Peter Mensink. (2010). Complications of single-balloon enteroscopy: a prospective evaluation of 166 procedures. Endoscopy. 42(5). 365–368. 73 indexed citations

18.

Ridder, Lissy de, Rinse K. Weersma, Gerard Dijkstra, et al.. (2007). Genetic susceptibility has a more important role in pediatric-onset Crohnʼs disease than in adult-onset Crohnʼs disease. Inflammatory Bowel Diseases. 13(9). 1083–1092. 79 indexed citations

19.

Ridder, Lissy de, Johanna C. Escher, J. Bouquet, et al.. (2004). Infliximab Therapy in 30 Patients With Refractory Pediatric Crohn Disease With and Without Fistulas in The Netherlands. Journal of Pediatric Gastroenterology and Nutrition. 39(1). 46–52. 8 indexed citations

20.

Verdonck, Anna, Lissy de Ridder, Geert Verbeke, et al.. (1998). Comparative effects of neonatal and prepubertal castration on craniofacial growth in rats. Archives of Oral Biology. 43(11). 861–871. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact